Ambri Inc - Cambridge, Massachusetts 02139

Ambri Inc is categorized under Research and Development Laboratories in Cambridge, MA .

Business Name: Ambri Inc
Contact Person: Phil Guidice
Address: 237 Putnam Avenue, Cambridge, Massachusetts 02139
Phone Number: (617) 714-5723
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:
Related Businesses: Ektek LLC - Cambridge, MA 02139
Sunpoint Technologies Inc - Cambridge, MA 02139
Aramark - Cambridge, MA 02139
Twin Lights Bioscience Inc - Cambridge, MA 02139
Good Start Genetics Inc - Cambridge, MA 02139
Hybrid Silica Technologies Inc - Cambridge, MA 02139
Unison Technologies LLC - Cambridge, MA 02139
H3 Biomedicine Inc - Cambridge, MA 02139
Gemedy Inc - Cambridge, MA 02139
Axios Biosciences LLC - Cambridge, MA 02139
Seaside Therapeutics LLC - Cambridge, MA 02139
Epieye Technologies - Cambridge, MA 02139
Realtime Technologies Limited - Cambridge, MA 02139
Srinivas Tejaswinhi - Cambridge, MA 02139
Simba Medical LLC - Cambridge, MA 02139
Axia Systems Technology Inc - Cambridge, MA 02139
Q-State Biosciences Inc - Cambridge, MA 02139
Oravax Inc - Cambridge, MA 02139
One Cell - Cambridge, MA 02139
Archemix Corp - Cambridge, MA 02139

The company Ambri Inc provides B2B services in the form of Research and Development Laboratories from its branch in Massachusetts. 1 to 4 employees work for Ambri Inc, and the business now earns Unknown per annum.

Ambri Inc was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact Ambri Inc, please call Phil Guidice with the phone number (617) 714-5723 or visit its branch at 237 Putnam Avenue in Cambridge, Massachusetts 02139.

The location of the branch can also be found using the coordinates 42.363495,-71.113894. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.